Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

UCB granted rights to Biogen's Tecfidera and other MS therapies in Asia

30.01.2014 / Scripintelligence

The deal will see UCB gain the rights to market bestselling oral MS therapy Tecfidera as well as Biogen's other MS products, which include:

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: